News
20.06.2025
Understanding Scleroderma and Its Diagnostic Tests
June is recognized as Scleroderma Awareness Month to honor those affected by the disease. The month ends with World Scleroderma Day on June 29. This date commemorates Swiss painter Paul Klee, who died of systemic sclerosis in 19401. Scleroderma, or systemic sclerosis, is a rare autoimmune disease. It causes hardening and tightening of the skin […]
More details
05.05.2025
Diagnostic Guidelines for Celiac Disease: Managing the Selective IgA Deficiency Challenge
Celiac disease (CD) diagnosis has advanced significantly over the past decade. Global guidelines now emphasize a combination of serology, genetics, and histology. While regional approaches differ, all aim for accurate diagnosis with minimal invasiveness. Core serological markers include antibodies against tissue transglutaminase (tTG), deamidated gliadin peptide (DG), and endomysial antibodies (EmA), assessed in both IgA […]
More details
26.03.2025
New Diagnostic Insights in Antiphospholipid Syndrome (APS) and Pregnancy
Antiphospholipid Syndrome (APS) is a major risk factor for pregnancy complications, yet diagnosing it remains challenging. Recent advancements in APS diagnostics provide deeper insights into its role in recurrent pregnancy loss and preeclampsia. Cutting-edge biomarker research and refined testing methods are improving accuracy, helping clinicians better identify at-risk patients and tailor treatment strategies. Discover the latest developments in APS diagnostics and their impact on maternal and fetal health.
More details
24.03.2025
Introducing our New Newsletter
Stay Ahead in Diagnostics and Subscribe to Our Medipan & GA Generic Assays‘ Newsletter In the fast-evolving field of diagnostics, staying informed is key. With the Medipan & GA Generic Assays newsletter, you gain exclusive access to our latest advancements, research insights, and innovative solutions in autoimmune and infectious disease diagnostics. Why Subscribe? As a […]
More details
04.03.2025
ICAP Update: Expansion of ANA Pattern Classification with AC-30 and AC-31
The International Consensus on ANA Patterns (ICAP) has taken another significant step in the continuous advancement to promote harmonization and understanding in antinuclear antibodies (ANA) of the HEp-2 IFA. As previously anticipated, in the ongoing update of the ANA pattern classification, two newly identified patterns, AC-30 and AC-31, have been incorporated into the ICAP nomenclature […]
More details
19.02.2025
Guillain-Barré Syndrome Outbreak: The Role of Anti-Ganglioside Antibodies Testing
A recent outbreak of Guillain-Barré Syndrome (GBS) in Pune, India, has seen approximately 160 reported cases since early January. The outbreak has been linked to Campylobacter jejuni, a foodborne pathogen and one of the leading causes of GBS worldwide1. Understanding Guillain-Barré Syndrome and Its Triggers GBS is a rare autoimmune disease where the immune system […]
More details
28.01.2025
Extended Shelf Life for Our RIA Kits for the determination of TSH, Tg, and Calcitonin
Extended Shelf Life for Our RIA Kits We are pleased to announce that our optimized production processes now ensure you receive RIA Kits SELco® TSH Rapid, SELco® Tg 1 Step, and SELco® Calcitonin with an extended shelf life of additional two weeks. Thanks to these improvements, we now complete the production process two weeks earlier, […]
More details
10.12.2024
Graves’ Disease: Understanding the Condition and the Importance of TRAb Detection
Graves’ Disease Graves’ disease (GD) is a prevalent autoimmune thyroid disorder and the leading cause of hyperthyroidism, affecting up to 1% of the population. It stands as one of the most common autoimmune diseases globally. It arises when the immune system produces thyroid-stimulating hormone receptor antibodies (TRAb), which bind to and activate the thyroid-stimulating hormone […]
More details
18.09.2024
RIA / IRMA Diagnostic Solutions at Medipan
Discover our products of the line RIA and IRMA
More details
13.05.2024
Investing in the future of diagnostics
GA Generic Assays receives funding from the Just Transition Fund (JTF) We are very pleased that GA Generic Assays has received funding from the Just Transition Fund (JTF) for the expansion of our existing facility. The aim of this project is to expand our production of immunological test kits for the serological diagnosis of autoimmune […]
More details